There is no highly effective vaccine against tuberculosis (TB), which remains an infection of global concern. Charles ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...

Finally, Mendus unveiled new data from its phase 1 ALISON trial of vididencel (DCP-001) – an off-the-shelf allogeneic dendritic cell-based vaccine – in high-grade serous ovarian cancer (HGSOC ...

In this exclusive interview with the WSWS, Dr. Daszak recounts the story of his persecution and that of other principled ...

The event took place at Trump National Golf Club in Sterling, Virginia, where as many as 220 top holders of his family’s ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Over the past decade, lipid nanoparticles (LNPs) have become a cornerstone in the field of nucleic acid delivery, with applications extending from vaccines ...

The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...

A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have ...

Article continues below The same technology is now being used to develop cancer vaccines which help the body recognise and kill cancer cells. They could even be given to people at genetic risk of ...